These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

774 related items for PubMed ID: 7986116

  • 1. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M, Kotake T.
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
    Kuroda M, Meguro N, Maeda O, Saiki S, Kinouchi T, Usami M, Kotake T.
    Cancer Chemother Pharmacol; 1994 Oct; 35 Suppl():S9-13. PubMed ID: 7527736
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 7. [Current status of adjuvant chemotherapy of invasive bladder cancer].
    Ozono S, Sasaki K, Watanabe S, Maruyama Y, Ohara S, Babaya K, Yamada K, Hirao Y, Okajima E.
    Hinyokika Kiyo; 1991 Dec; 37(12):1589-95. PubMed ID: 1785379
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 9. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for poor prognosis patients with urothelial tumors and effect of dose intensity.
    Hibi H, Okamura K, Takashi M, Shimoji T, Miyake K.
    Hinyokika Kiyo; 1997 Feb; 43(2):89-96. PubMed ID: 9086342
    [Abstract] [Full Text] [Related]

  • 10. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [Abstract] [Full Text] [Related]

  • 11. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
    Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD.
    Cancer; 2012 Aug 15; 118(16):3920-7. PubMed ID: 22614698
    [Abstract] [Full Text] [Related]

  • 12. [Neoadjuvant chemotherapy for invasive bladder cancer].
    Kageyama Y, Kihara K.
    Gan To Kagaku Ryoho; 2001 Nov 15; 28(12):1838-44. PubMed ID: 11729476
    [Abstract] [Full Text] [Related]

  • 13. [Neoadjuvant chemotherapy (M-VAC) for locally invasive bladder cancer].
    Kamoto T, Kawakita M, Okabe T, Matsumoto M, Matsuda T, Yoshida O.
    Hinyokika Kiyo; 1992 Apr 15; 38(4):405-11. PubMed ID: 1529813
    [Abstract] [Full Text] [Related]

  • 14. [Postoperative adjuvant M-VAC chemotherapy for invasive bladder cancer].
    Yamashita S, Taniguchi K, Morimitsu H, Suzu H, Kanetake H, Saito Y, Yushita Y, Sakuragi T.
    Hinyokika Kiyo; 1992 May 15; 38(5):519-24. PubMed ID: 1609658
    [Abstract] [Full Text] [Related]

  • 15. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N.
    J Urol; 1996 Jun 15; 155(6):1897-902. PubMed ID: 8618282
    [Abstract] [Full Text] [Related]

  • 16. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
    Miyanaga N, Akaza H.
    Gan To Kagaku Ryoho; 2007 Nov 15; 34(11):1745-9. PubMed ID: 18030008
    [Abstract] [Full Text] [Related]

  • 17. [The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
    Stöckle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    Ann Urol (Paris); 1993 Nov 15; 27(1):51-7. PubMed ID: 7682388
    [Abstract] [Full Text] [Related]

  • 18. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
    Nieuwenhuijzen JA, Bex A, Meinhardt W, Kerst JM, Schornagel JH, VAN Tinteren H, Horenblas S.
    J Urol; 2005 Jul 15; 174(1):80-5. PubMed ID: 15947583
    [Abstract] [Full Text] [Related]

  • 19. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J, Franzaring L, Thüroff J, Wellek S, Stöckle M.
    BJU Int; 2006 Jan 15; 97(1):42-7. PubMed ID: 16336326
    [Abstract] [Full Text] [Related]

  • 20. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A.
    Gan To Kagaku Ryoho; 1990 Sep 15; 17(9):1909-15. PubMed ID: 2393308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.